You are here: Home » Reuters » News
Business Standard

Pfizer Japan recalls high blood pressure drug over cancer-causing impurity

Reuters  |  TOKYO 

(Reuters) - The Japanese subsidiary of Inc is recalling a drug for which was found to contain a carcinogenic substance in its valsartan, the drugmaker said on Friday.

More than 763,000 tablets of the drug Amvalo, manufactured from April to July in in India, are the subject of recall, Japan Inc said in a statement, adding there were no reports of any damage to health.

"We will fully pay careful attention to our and quality control to prevent a recurrence," Japan said.

said in November it would recall certain batches of blood pressure medicine in the after they were found to contain a probable cancer-causing impurity.

Chinese also said in July it would recall from consumers in the after finding traces of a probable carcinogen.

Last year, the asked to check whether any of their drugs using contained any carcinogenic impurities.

(Reporting by Takashi Umekawa; Editing by Alexander Smith)

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

First Published: Fri, February 08 2019. 20:23 IST